The offering is slated to close Nov. 29 with the underwriter holding a 30-day option to buy up to 1.2 million additional shares, according to the biopharmaceutical company's statement.
Shares were down nearly 17% in after-hours trading.
Price: 1.3000, Change: -0.26, Percent Change: -16.67
|Street Color: Global Calendar For Week Ending May 20|
|Ryder System Receives $4.4 Billion Cash Buyout Propo...|
|Payoneer Shares Rally After Q1 Beats Expectations, 2...|
|Market Chatter: Alibaba Group's Venture in Russia Re...|
|Research Alert: CFRA Raises View On Paycom Software ...|